Dr. Gregory J. Panzo, MD

Dr. Panzo practices at Surgery Center of The Villages - Stonecrest in Summerfield, Florida.

Dr. Panzo's NPI, 1457354573, was assigned on May 23, 2005. Dr. Panzo graduated from Lewis Katz School of Medicine in 1979. Dr. Panzo holds Florida license ME0046534.

Dr. Panzo's primary practice is Surgery Center of the Villages - Stonecrest, at 17560 Se 109 Terrace Road, Summerfield, FL 34491. The practice phone is (352) 735-2020. Dr. Panzo also practices at The Surgery Center of the Villages, 17556 Se 109th Terrace Rd, Summerfield, FL 34491.

Dr. Panzo's primary practice is Surgery Center of The Villages - Stonecrest in Summerfield, Florida. Dmand AI also links Dr. Panzo to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Panzo practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Panzo's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Panzo is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Panzo's licenses on file in 3 states: Florida, Ohio and Iowa.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, eye infection or inflammation, eyelid inflammation, glaucoma, glaucoma surgery and hereditary corneal conditions among the conditions Dr. Panzo treats.

CMS data shows 4,071 Medicare services from Dr. Panzo across 16 procedure codes in 2024, for 1,015 Medicare patients. Medicare paid $271,236 for them.

CMS counts 1,015 Medicare patients who saw Dr. Panzo in 2024. The largest group is 75 to 84, with 507 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Panzo's median patient age at 77, with 57% women.

In 2024, Dr. Panzo wrote 4,494 Medicare Part D claims for 1,100 patients. 68% of them were for generic drugs. CMS names the drug for 4,401 of them, across 28 drugs with 11 or more claims each, at $449,126 in total drug cost. In 2023, CMS named 6,142 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Panzo for performance year 2024, reported as part of a group. Dr. Panzo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 324 procedures of cataract surgery by Dr. Panzo, more than 90% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Panzo.

Dmand AI links Dr. Panzo to 5 clinical trials, 2 of them phase 2 studies. Conditions studied include Glaucoma, Ocular Hypertension and Cataract. Heidelberg Engineering GmbH sponsors the most, 2.

CMS Open Payments shows 301 general payments to Dr. Panzo from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 79% of the total. Alcon Laboratories Inc paid the most, $5,368.

Dmand AI lists 2 awards for Dr. Panzo, most recently CMS Stage 1 EHR in 2013.

Dr. Panzo graduated from Lewis Katz School of Medicine in 1979. Dr. Panzo is a member of AAO.

Dr. Panzo is in network with 16 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.